|
Volumn 161, Issue 9, 2004, Pages 1718-1719
|
Atomoxetine and nonresponders to stimulants [7]
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATOMOXETINE;
CENTRAL STIMULANT AGENT;
GENERIC DRUG;
IMIPRAMINE;
NORADRENALIN;
ATTENTION DEFICIT DISORDER;
CHILD BEHAVIOR;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG CHOICE;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
EDUCATION PROGRAM;
HUMAN;
INTELLIGENCE QUOTIENT;
LEARNING DISORDER;
LETTER;
PATIENT EDUCATION;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
TREATMENT OUTCOME;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CHILD;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DRUG ADMINISTRATION SCHEDULE;
DRUG COSTS;
HUMANS;
PROPYLAMINES;
PSYCHIATRIC STATUS RATING SCALES;
TREATMENT OUTCOME;
|
EID: 4444267262
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (7)
|
References (4)
|